Magellan Health, Inc. (MGLN) Financial Statements (2026 and earlier)

Company Profile

Business Address 4801 E. WASHINGTON ST
PHOENIX, AZ 85034
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 806 - Hospitals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments326626 9376350
Short-term investments326626 9376350
Restricted cash and investments136127 98102167
Receivables827794 769753924
Inventory, net of allowances, customer advances and progress billings3946 383742
Inventory3946 383742
Disposal group, including discontinued operation    1,1441,146 
Other current assets145101 9680107
Other undisclosed current assets542329 5458217
Total current assets:2,0152,023 2,2912,2521,807
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization1112 1313 
Operating lease, right-of-use asset3232 1721 
Property, plant and equipment      143
Long-term investments and receivables 35 6 6
Long-term investments 35 6 6
Intangible assets, net (including goodwill)938945 8598691,171
Goodwill874874 8068061,018
Intangible assets, net (excluding goodwill)6472 5262153
Deferred income tax assets  1 26291
Other noncurrent assets120120 686196
Other undisclosed noncurrent assets9898 101107 
Total noncurrent assets:1,2031,213 1,0901,0991,418
TOTAL ASSETS:3,2183,237 3,3813,3513,225
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities341416 357286425
Accounts payable132150 12299104
Accrued liabilities208266 235187321
Deferred revenue77 122639
Debt39 48584
Disposal group, including discontinued operation    496504 
Other undisclosed current liabilities279231 231197482
Total current liabilities:630662 1,1011,0981,030
Noncurrent Liabilities
Long-term debt and lease obligation, including:522527 637642648
Finance lease, liability1011 131415
Other undisclosed long-term debt and lease obligation479482 600618591
Liabilities, other than long-term debt4237 232250
Deferred revenue1111 111111
Deferred income tax liabilities1814   23
Liability for uncertainty in income taxes1312 121116
Operating lease, liability3334 241041
Other undisclosed noncurrent liabilities6868 414665
Total noncurrent liabilities:631631 701710763
Total liabilities:1,2601,294 1,8021,8081,793
Temporary equity, including noncontrolling interest3433    
Equity
Equity, attributable to parent1,9241,910 1,5791,5431,432
Common stock11 111
Treasury stock, value(1,465)(1,465) (1,465)(1,465)(1,465)
Additional paid in capital1,5041,489 1,4551,4301,403
Accumulated other comprehensive income (loss)(0)(0) 01(0)
Retained earnings1,8841,885 1,5881,5771,493
Total equity:1,9241,910 1,5791,5431,432
TOTAL LIABILITIES AND EQUITY:3,2183,237 3,3813,3513,225

Income Statement (P&L) ($ in millions)

9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
Revenues1,2211,162(3,393)1,1701,1001,794
Cost of revenue
(Cost of Product and Service Sold)
(521)(492) (560)(528)(486)
Other undisclosed gross profit(668)(594) (576)(515)(1,233)
Gross profit:3275 345775
Operating income:3275 345775
Interest and debt expense(6)(6) (7)(8)(9)
Other undisclosed loss from continuing operations before equity method investments, income taxes  (29) (46)(38)(31)
Income (loss) from continuing operations before equity method investments, income taxes:2639 (20)1135
Other undisclosed loss from continuing operations before income taxes(34)     
Income (loss) from continuing operations before income taxes:(8)39 (20)1135
Income tax expense (benefit)1(11) 236(17)
Income (loss) from continuing operations:(6)29 (17)4718
Income (loss) before gain (loss) on sale of properties:(6)29(17)4718
Other undisclosed net loss  (1)    
Net income (loss):(6)28 (17)4718
Other undisclosed net income attributable to parent6  2936 
Net income (loss) attributable to parent:(1)28 128418
Other undisclosed net loss available to common stockholders, basic      
Net income (loss) available to common stockholders, diluted:(1)28 128418

Comprehensive Income ($ in millions)

9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
Net income (loss):(6)28 (17)4718
Other comprehensive income (loss)00 (0)1(0)
Comprehensive income (loss):(6)28 (18)4818
Other undisclosed comprehensive income, net of tax, attributable to parent6  2936 
Comprehensive income (loss), net of tax, attributable to parent:(0)28 118418

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: